- call +1-201-465-4211
- email sales@mrinsights.biz
Interventional oncology is a subspecialty field of interventional radiology that deals with the diagnosis and treatment of cancerand cancer-related problems using targeted minimally invasive procedures performed under image guidance.
Scope of the Report:
This report studies the Interventional Oncology market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Interventional Oncology market by product type and applications/end industries.
Interventional oncology has developed to a separate pillar of modern oncology and it employs X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to help guide miniaturized instruments (e.g. biopsy needles, ablation electrodes, intravascular catheters) to allow targeted and precise treatment of solid tumours located in various organs of the human body, including but not limited to the liver, kidneys, lungs, and bones. Interventional oncology treatments are routinely carried out by interventional radiologists in appropriate settings and facilities.
The global Interventional Oncology market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Interventional Oncology.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Boston Scientific
BTG
Medtronic
Merit Medical
Terumo
Accuray
Alpinion Medical Systems
Angiodynamics
Atricure
Baylis Medical
Bovie Medical
Brainlab
Bsd Medical
C. R. Bard
C2 Therapeutics
Cardiofocus
Cook Medical
Eckert And Ziegler Bebig
Edap Tms
Elekta
Galil Medical
Healthtronics
Insightec
Medwaves
Mermaid Medical
Microsulis Medical
Monteris Medical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Radiation Therapy
Ablation
Particle Embolization
Market Segment by Applications, can be divided into
Liver Cancer
Lung Cancer
Kidney Cancer
Bone Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Interventional Oncology Market Overview
1.1 Product Overview and Scope of Interventional Oncology
1.2 Classification of Interventional Oncology by Types
1.2.1 Global Interventional Oncology Revenue Comparison by Types (2017-2023)
1.2.2 Global Interventional Oncology Revenue Market Share by Types in 2017
1.2.3 Radiation Therapy
1.2.4 Ablation
1.2.5 Particle Embolization
1.3 Global Interventional Oncology Market by Application
1.3.1 Global Interventional Oncology Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Liver Cancer
1.3.3 Lung Cancer
1.3.4 Kidney Cancer
1.3.5 Bone Cancer
1.3.6 Breast Cancer
1.3.7 Prostate Cancer
1.3.8 Pancreatic Cancer
1.4 Global Interventional Oncology Market by Regions
1.4.1 Global Interventional Oncology Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Interventional Oncology Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Interventional Oncology Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Interventional Oncology Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Interventional Oncology Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Interventional Oncology Status and Prospect (2013-2023)
1.5 Global Market Size of Interventional Oncology (2013-2023)
2 Manufacturers Profiles
2.1 Boston Scientific
2.1.1 Business Overview
2.1.2 Interventional Oncology Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Boston Scientific Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.2 BTG
2.2.1 Business Overview
2.2.2 Interventional Oncology Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 BTG Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.3 Medtronic
2.3.1 Business Overview
2.3.2 Interventional Oncology Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Medtronic Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merit Medical
2.4.1 Business Overview
2.4.2 Interventional Oncology Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merit Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.5 Terumo
2.5.1 Business Overview
2.5.2 Interventional Oncology Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Terumo Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.6 Accuray
2.6.1 Business Overview
2.6.2 Interventional Oncology Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Accuray Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.7 Alpinion Medical Systems
2.7.1 Business Overview
2.7.2 Interventional Oncology Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Alpinion Medical Systems Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.8 Angiodynamics
2.8.1 Business Overview
2.8.2 Interventional Oncology Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Angiodynamics Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.9 Atricure
2.9.1 Business Overview
2.9.2 Interventional Oncology Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Atricure Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.10 Baylis Medical
2.10.1 Business Overview
2.10.2 Interventional Oncology Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Baylis Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.11 Bovie Medical
2.11.1 Business Overview
2.11.2 Interventional Oncology Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Bovie Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.12 Brainlab
2.12.1 Business Overview
2.12.2 Interventional Oncology Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Brainlab Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.13 Bsd Medical
2.13.1 Business Overview
2.13.2 Interventional Oncology Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Bsd Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.14 C. R. Bard
2.14.1 Business Overview
2.14.2 Interventional Oncology Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 C. R. Bard Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.15 C2 Therapeutics
2.15.1 Business Overview
2.15.2 Interventional Oncology Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 C2 Therapeutics Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.16 Cardiofocus
2.16.1 Business Overview
2.16.2 Interventional Oncology Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Cardiofocus Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.17 Cook Medical
2.17.1 Business Overview
2.17.2 Interventional Oncology Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Cook Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.18 Eckert And Ziegler Bebig
2.18.1 Business Overview
2.18.2 Interventional Oncology Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Eckert And Ziegler Bebig Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.19 Edap Tms
2.19.1 Business Overview
2.19.2 Interventional Oncology Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Edap Tms Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.20 Elekta
2.20.1 Business Overview
2.20.2 Interventional Oncology Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Elekta Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.21 Galil Medical
2.21.1 Business Overview
2.2.2 Interventional Oncology Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Galil Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.22 Healthtronics
2.22.1 Business Overview
2.22.2 Interventional Oncology Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Healthtronics Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.23 Insightec
2.23.1 Business Overview
2.23.2 Interventional Oncology Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Insightec Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.24 Medwaves
2.24.1 Business Overview
2.24.2 Interventional Oncology Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Medwaves Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.25 Mermaid Medical
2.25.1 Business Overview
2.25.2 Interventional Oncology Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Mermaid Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.26 Microsulis Medical
2.26.1 Business Overview
2.26.2 Interventional Oncology Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Microsulis Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.27 Monteris Medical
2.27.1 Business Overview
2.27.2 Interventional Oncology Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 Monteris Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
3 Global Interventional Oncology Market Competition, by Players
3.1 Global Interventional Oncology Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Interventional Oncology Players Market Share
3.2.2 Top 10 Interventional Oncology Players Market Share
3.3 Market Competition Trend
4 Global Interventional Oncology Market Size by Regions
4.1 Global Interventional Oncology Revenue and Market Share by Regions
4.2 North America Interventional Oncology Revenue and Growth Rate (2013-2018)
4.3 Europe Interventional Oncology Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Interventional Oncology Revenue and Growth Rate (2013-2018)
4.5 South America Interventional Oncology Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Interventional Oncology Revenue and Growth Rate (2013-2018)
5 North America Interventional Oncology Revenue by Countries
5.1 North America Interventional Oncology Revenue by Countries (2013-2018)
5.2 USA Interventional Oncology Revenue and Growth Rate (2013-2018)
5.3 Canada Interventional Oncology Revenue and Growth Rate (2013-2018)
5.4 Mexico Interventional Oncology Revenue and Growth Rate (2013-2018)
6 Europe Interventional Oncology Revenue by Countries
6.1 Europe Interventional Oncology Revenue by Countries (2013-2018)
6.2 Germany Interventional Oncology Revenue and Growth Rate (2013-2018)
6.3 UK Interventional Oncology Revenue and Growth Rate (2013-2018)
6.4 France Interventional Oncology Revenue and Growth Rate (2013-2018)
6.5 Russia Interventional Oncology Revenue and Growth Rate (2013-2018)
6.6 Italy Interventional Oncology Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Interventional Oncology Revenue by Countries
7.1 Asia-Pacific Interventional Oncology Revenue by Countries (2013-2018)
7.2 China Interventional Oncology Revenue and Growth Rate (2013-2018)
7.3 Japan Interventional Oncology Revenue and Growth Rate (2013-2018)
7.4 Korea Interventional Oncology Revenue and Growth Rate (2013-2018)
7.5 India Interventional Oncology Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Interventional Oncology Revenue and Growth Rate (2013-2018)
8 South America Interventional Oncology Revenue by Countries
8.1 South America Interventional Oncology Revenue by Countries (2013-2018)
8.2 Brazil Interventional Oncology Revenue and Growth Rate (2013-2018)
8.3 Argentina Interventional Oncology Revenue and Growth Rate (2013-2018)
8.4 Colombia Interventional Oncology Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Interventional Oncology by Countries
9.1 Middle East and Africa Interventional Oncology Revenue by Countries (2013-2018)
9.2 Saudi Arabia Interventional Oncology Revenue and Growth Rate (2013-2018)
9.3 UAE Interventional Oncology Revenue and Growth Rate (2013-2018)
9.4 Egypt Interventional Oncology Revenue and Growth Rate (2013-2018)
9.5 Nigeria Interventional Oncology Revenue and Growth Rate (2013-2018)
9.6 South Africa Interventional Oncology Revenue and Growth Rate (2013-2018)
10 Global Interventional Oncology Market Segment by Type
10.1 Global Interventional Oncology Revenue and Market Share by Type (2013-2018)
10.2 Global Interventional Oncology Market Forecast by Type (2018-2023)
10.3 Radiation Therapy Revenue Growth Rate (2013-2023)
10.4 Ablation Revenue Growth Rate (2013-2023)
10.5 Particle Embolization Revenue Growth Rate (2013-2023)
11 Global Interventional Oncology Market Segment by Application
11.1 Global Interventional Oncology Revenue Market Share by Application (2013-2018)
11.2 Interventional Oncology Market Forecast by Application (2018-2023)
11.3 Liver Cancer Revenue Growth (2013-2018)
11.4 Lung Cancer Revenue Growth (2013-2018)
11.5 Kidney Cancer Revenue Growth (2013-2018)
11.6 Bone Cancer Revenue Growth (2013-2018)
11.7 Breast Cancer Revenue Growth (2013-2018)
11.8 Prostate Cancer Revenue Growth (2013-2018)
11.9 Pancreatic Cancer Revenue Growth (2013-2018)
12 Global Interventional Oncology Market Size Forecast (2018-2023)
12.1 Global Interventional Oncology Market Size Forecast (2018-2023)
12.2 Global Interventional Oncology Market Forecast by Regions (2018-2023)
12.3 North America Interventional Oncology Revenue Market Forecast (2018-2023)
12.4 Europe Interventional Oncology Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Interventional Oncology Revenue Market Forecast (2018-2023)
12.6 South America Interventional Oncology Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Interventional Oncology Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Interventional Oncology Picture
Table Product Specifications of Interventional Oncology
Table Global Interventional Oncology and Revenue (Million USD) Market Split b
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
